Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Neoadjuvant therapy is associated with altered composition of immune cell infiltration and an anti-tumorigenic microenvironment in resected pancreatic cancer Costa, A., Vayrynen, S., Chawla, A., Zhang, J., Vayrynen, J. P., Lau, M., Williams, H. L., Yuan, C., Morales-Oyarvide, V., Rubinson, D. A., Clancy, T. E., Brais, L. K., Reilly, E., Kozak, M. M., Linehan, D. C., Dunne, R. F., Chang, D. T., Hezel, A. F., Koong, A. C., Aguirre, A. J., Wolpin, B. M., Nowak, J. A. AMER ASSOC CANCER RESEARCH. 2020
View details for DOI 10.1158/1538-7445.PANCA20-PR-001
View details for Web of Science ID 000617413700080